A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

The NIH plans to develop whole-virus vaccines that would provide universal immunity against all strains of influenza and COVID-19.

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

The US Department of Health and Human Services (HHS) has launched a $500m initiative to accelerate the development of ...